期刊文献+

血培养联合降钙素原与超敏C反应蛋白在新生儿败血症早期诊断中的应用 被引量:23

Discussion of the value of the application of blood culture,the serum procalcitonin and high sensitivity creactive protein in neonatal sepsis patients
下载PDF
导出
摘要 目的探讨血培养联合血清降钙素原(PCT)和超敏C反应蛋白(hs-CRP)检测在诊断新生儿败血症中的应用。方法采用固相免疫色谱法和免疫比浊法分别测定新生儿败血症患儿的PCT、hs-CRP浓度,并与血培养结果比较。结果与对照组相比,败血症组患儿中PCT和hs-CRP水平明显升高,差异有统计学意义(P<0.01);败血症组患儿血培养结果与PCT结果比较差异无统计学意义(P>0.05),败血症组患儿血培养结果与hs-CRP结果比较差异有统计学意义(P<0.01)。结论 PCT与hs-CRP均可作为早期识别新生儿败血症及其严重性的重要指标,可作为血培养的重要补充指标。 Objective To evaluate the clinical significance of the detection of blood culture,serum procalcitonin(PCT) and high sensitivity C-reactive protein(hs-CRP) in the diagnosis of neonatal sepsis.Methods Solid-phase immune chromatography and immune nephelometry were used to determine the levels of serum PCT and CRP in neo-natal sepsis patients,and the test was data compared with the results of blood culture.Results The levels of PCT and CRP in the neonatal sepsis group were significantly higher than those in the controls(P〈0.01) .However,the levels of PCT compared with the results of blood culture in the neonatal sepsis group were not significant(P〉0.05) ,while the levels of hs-CRP,compared with the results of blood culture in the same group,were significant(P〈0.01) . Conclusion Both PCT and CRP are the important makers for early diagnosis of neonatal sepsis,and can make the im-portant supplement experiment of the blood culture.
出处 《检验医学与临床》 CAS 2010年第21期2328-2329,共2页 Laboratory Medicine and Clinic
关键词 新生儿败血症 血培养 降钙素原 超敏C反应蛋白 neonatal sepsis blood culture procalcitonin high sensitivity C-reactive protein
  • 相关文献

参考文献9

二级参考文献49

  • 1时兢,宋秀琴,谢卫星,陆荣国,王烨,衡军锋.降钙素原对脓毒症的早期诊断价值[J].中华检验医学杂志,2004,27(6):385-386. 被引量:26
  • 2王吉勇,周业模,姜领.降钙素原检测在早期鉴别患儿急性细菌性与病毒性脑炎的临床应用[J].检验医学,2004,19(5):389-389. 被引量:11
  • 3席云,肖刚,吴坚,文博.BACTEC^(TM)9120全自动血培养系统应用评价[J].国际医药卫生导报,2004,10(22):90-91. 被引量:4
  • 4吴仕孝.新生儿败血症诊断标准修订方案[J].中华儿科杂志,1988,26:163-164.
  • 5Zeni F,Viallon A,Assicot M,et al.Procalcitonin serum concentrations and severity of sepsis[J].Clin Intens Care,1994,5 (suppl2):89-98.
  • 6Anonymous.Americn college of chest physicians/society of critical care medicine consensus conference:definitions for sepsis and organ failure and guidelines for the use innovative therapies in sepsis[J].Crit Care Med,1992,20:864-874.
  • 7Bone RC.Definition for sepsis and organ failure[J].Crit Care Med,1992,19:973 -976.
  • 8Hergert M,Lestin HG,Scherkus,et al.Proeacitonin in patients with sepsis and polytrauma[J].Cfin Lab,1998,44:659-670.
  • 9Oberhoffer M,Bitterlich A,Hentsche,et al.Procacitonin correlates better with the ACCP/SCCM consensus conference definitions than other specific markers of the inflammatory response[J].Clin Intens Care,1996,22:A245.
  • 10Gibot S,Cravoisy A,Kolopp-Sarda MN,et al.Time-course of sTREM (soluble triggering receptor expressed on myeloid cells) -1,procalcitonin,and C-reactive protein plasma concentrations during sepsis[J].Crit Care Med,2005,33 (4):792-796.

共引文献101

同被引文献167

引证文献23

二级引证文献211

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部